1.Effect of rosuvastatin on the expression of vascular cell adhesion molecule-1 of renal tissue in patients with the early-stage diabetic nephropathy
Chinese Journal of Postgraduates of Medicine 2011;34(28):10-13
Objective To observe the effect of rosuvastatin on the expression of vascular cell adhesion molecule-1 (VCAM-1) of renal tissue in patients with the early-stage diabetic nephropathy.Methods Sixty patients with early-stage diabetic nephropathy were divided into two groups by random digits table:rosuvastatin group and regular group.The patients were given 10 mg/d rosuvastatin besides the conventional treatment in rosuvastatin group.The levels of blood glucose,blood fat,renal function,high sensitivity C-reactive protein(hs-CRP),urine albumin excretion rate(UAER) and the expression of VCAM-1 were observed.Results Compared with those before treatment,the levels of total cholesterol (TC),low density lipoprotein cholesterol (LDL-C),trtglyeride (TG) showed no decrease after treatment [(5.83 ± 1.02),(3.48 ±0.60),(7.12 ±0.99) mmol/L] in regular group (P >0.05),but significantly decreased in rosuvastatin group [ (4.51 ± 0.95 ),( 3.18 ± 0.47),(7.02 ± 0.87 ) mmol/L ] (P < 0.01 ).The levels of UAER and hs-CRP were significantly decreased in regular group and rosuvastatin group after treatment [ (78.3 ±31.7),(53.8 ± 24.9) μ g/min,and (2.15 ± 0.48),( 1.59 ± 0.55) mg/L] (P< 0.01 ),then rosuvastatin groupwas more conspicuous than regular group (P < 0.05 ).The expression of VCAM-1 was less in rosuvastatin group than that in regular group.Conclusion Rosuvastatin can down-regulate the expression of VCAM-1 of kidney tissues in patients with the early-stage diabetic nephropathy and these indicate that rosuvastatin can reduce urine protein by inhibiting the inflammatory process.
2.Application of control-release preparations of growth factor in treating neurodegeneration diseases
International Journal of Biomedical Engineering 2006;0(05):-
Incorporation of growth factors in polymeric drug delivery systems serves to maintain its bioactivity and long-term sustained release. With the development of controlled release techniques from simple mixing growth factors with carrier materials to controlled release microspheres, this kind of delivery formulations gain their extensive application. The present review focused on the application of biodegradable delivery systems of growth factors in treating neurodegeneration diseases.
3.Clinical study of open versus endoscopic component separation with biological mesh reinforcement in treatment of patients with abdominal wall defects
International Journal of Surgery 2014;41(9):588-591,649
Objective To compare the operation effect of endoscopic versus open component separation on abdominal wall reconstruction.Methods From January 2012 to December 2013,19 patients (ECST 8 and CST 11) with abdominal wall defects were repaired with biomaterials mesh.This study analyzed retrospectively the clinical information between two groups.Results No hernia recurrences were occurred during a mean follow-up of (14.96± 8.89) months.There was no significant difference in EBL,operation time,length of stay.The rate of recurrence wound complications in CST group is higher than the ECST group,but is not significant difference.Conclusions Endoscopic or open component separation with biomaterials mesh could effectively repair the abdominal wall defect and ECST definitely showed the advantage in reducing the incisional complication.But the large sample,long-term clinical follow-up should be confirmed.
4.Strategies for functional repair of complex abdominal wall defects
Chinese Journal of Digestive Surgery 2015;14(10):813-815
It is still a challenge for surgeons to deal with the complex abdominal wall defect.The purpose of surgical treatment is not only to restore the integrity of the abdominal wall, but also to maintain the function of the abdominal wall.Accurate classification and partition of the abdominal wall defects before operation are the base of surgical procedure for complex abdominal wall defects.Reinforcement of the abdominal wall defects with mesh, component separation technique and tissue flap technique are important methods to achieve functional repair of the abdominal wall defects.
6.Progress in markerless knockout of chromosome genes in Streptomycetes.
Yanyan GU ; Weitao GENG ; Cunjiang SONG
Chinese Journal of Biotechnology 2013;29(8):1100-1112
Streptomycetes are Gram-positive bacteria of Actinomycetales. These organisms can produce many economically important secondary metabolites. With the development of molecular biology, gene sequencing technology and synthetic biology, people gained a better understanding of the Streptomyces family. The means to transform genome on the molecular level is also increasing. By simplifying the Streptomyces genome rationally and efficiently, it will improve the yield and quality of the metabolites as well as reduce the consumption of the substrates. Markerless knockout is an important way to carry out genetic modification. Here we describe novel genome modification techniques developed for Streptomyces in recent years with focus on the markerless knockout technologies.
Chromosomes, Bacterial
;
genetics
;
Gene Knockout Techniques
;
methods
;
Genes, Bacterial
;
genetics
;
Streptomyces
;
genetics
7.Overview on development of traditional and complementary medicine in Malaysia
Xiangdong LI ; Li SONG ; Xiaojun GU
International Journal of Traditional Chinese Medicine 2010;32(1):86-87
Traditional and complementary medicine system in Malaysia is composed of traditional Malay medicine (TMM),traditional Chinese medicine(TCM),traditional Indian medicine(TIM),homeopathy and other complementary medicine.Traditional and Complementary Medicine Division is the official body responsible for T/CM administration.Malaysia concentrates on 4 main areas of traditional and complementary medicine i.e.product,practices,training and research.The government of Malaysia is devoted to facilitate the integration of Traditional and Complementary Medicine into the Malaysian Healthcare system in recent years.
8.Extracranial-intracranial arterial bypass for ischemic cerebrovascular disease
Wei NI ; Yuxiang GU ; Donglei SONG
International Journal of Cerebrovascular Diseases 2009;17(6):452-458
Extracranial-intracranial arterial bypass, an elegant procedure, was first performed and developed gradually by M. Gazi Yasargil. It has been used in the management of ischemic cerebrovascular disease, moyamoya disease, intracranial aneurysms and brain tumors.This article focuses on its application in the ischemic cerebrovascular disease, and reviews it from the aspects of cerebral hemodynamics of ischemic cerebrovascular disease, indications for arterial bypass, preoperative evaluation, operating modes, intraoperative assessment,complications, postoperative care and prognosis.
9.Capsular tension ring implantation for congenital subluxated lenses
Yu ZHENG ; Xudong SONG ; Zheng GU
Ophthalmology in China 1994;0(02):-
1.5mm)and received CTR scleral fixation.Visual acuity before and after surgery were examined.IOL tilt and decentration were measured with PentaCam system.Complications were also recorded.Main Outcome Measures Postoperative visual improvement,IOL position and complications.Results At the last postoperative examination,best corrected visual acuities of all eyes were increased(P=0.000).The mean IOL tilt was 4.33?2.96?before and 4.11?2.05?after CTR fixation,the mean decentration was 2.56?0.90mm before and 1.19?0.71mm after.No significant differences were found in IOL tilt before and after CTR fixation(P=0.844),but there were significant differences in IOL decentration(P=0.009).Posterior capsular opacification was found in 8 eyes(20.5%)during the follow-up period,and 2 eyes(5.1%)received Nd:YAG posterior capsulotomy.1 eye received IOL scleral fixation because of capsule rupture during CTR implantation.2 eyes suffered from temporary IOP elevation after surgery.No other severe complications occurred.Conclusions Phacoemulsification with CTR and IOL implantation is effective and safe for congenital subluxated lenses.CTR scleral fixation is a necessary supplement for severely subluxated lenses and progressive cases.
10.Low-dose amiodarone for prevention of atrial fibrillation after coronary artery bypass grafting
Song GU ; Pixiong SU ; Yan LIU
Chinese Journal of Thoracic and Cardiovascular Surgery 2003;0(02):-
Objective: To evaluate the effect, tolerance and safety of low-dose oral amiodarone in the prevention of AF after coronary artery bypass grafting (CABG). Methods: Between 1998 and 1999, 235 adult patients underwent CABG. They were given 0 6 g of amiodarone (80 patients) or placebo (155 patients) daily for 7 days before surgery and 0 2g of amiodarone or placebo daily for 30 days postoperatively. Results: The incidence of postoperative AF was significantly (P=0 001) lower in treatment group (10%) as compared with placebo (21 94%). Only 3 cases had pro-arrhythmic effects and no side effects in treatment group. Conclusion: 1.Perioperative low-dose oral amiodarone significantly reduced the ventricular rate and reduced occurrence and duration of atrial fibrillation after CABG. 2.Low-dose amiodarone is well tolerated and decreased the risks of severe side effects and pro-arrhythmic effects, especially for these patients with high risk factors in perioperative period.